Big pharma company Eli Lilly (LLY -1.81%) faces allegations of bribing medical doctors in China, just weeks after similar claims arose against its peers GlaxoSmithKline and Sanofi. In the following video, taken from The Motley Fool's health-care show, analysts David Williamson and Max Macaluso discuss this story and the potential impact of these claims on investors.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.